Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Standard of Care × CNS × Clear all

Phase

Phase NA 4 Phase 2 4 Phase 1 4 Phase EARLY_PHASE1 2 Phase 4 1 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3 Genitourinary 2 Gastrointestinal 2 Tumor-Agnostic 1 Plasma cell 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Interventions

Saline Solution 6 Dexmedetomidine 5 Sodium Chloride 4 Sevoflurane 3 Propofol 3 Levetiracetam 3 trametinib 2 perampanel 2 dabrafenib 2 Temozolomide 2 Sugammadex 2 Methylphenidate 2 Magnetic Resonance Spectroscopy 2 Granulocyte-Macrophage Colony-Stimulating Factor 2 Gentamicins 2 Fluorescein 2 Anesthesia, Inhalation 2 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 pembrolizumab 1 pegvisomant 1 naxitamab 1 lorlatinib 1 gadoterate meglumine 1 gadobenic acid 1 dexketoprofen trometamol 1 clevidipine 1 Vincristine 1 Valproic Acid 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02034799 2018-02-26

Phase IV Bioseal Study in Brain Tumor Surgery

Ethicon, Inc.

Phase 4 Completed

256 enrolled 16 charts

Hemostasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡